Merck scores a win in $1.4B insurance fight over devastating cyberattack esagonowsky Thu, 01/20/2022 – 09:30

Viatris yanks one batch of diabetes med Semglee because of missing label risks fkansteiner Thu, 01/20/2022 – 09:41

Goodbye Humira, hello Dupixent: Sanofi and Regeneron outspend AbbVie to top 2021’s pharma TV ad spenders badams Thu, […]

There’s no place like homeOlder patients with acute illness are often on the borderline between needing admission and […]

In 1999 we published a letter by Nicholas Wald and others that estimated that 45% of pregnant women […]

PrediabetesPrediabetes is a label applied to people with evidence of impaired glucose metabolism but whose glucose or HbA1c […]

Antibodies generated from only two vaccine doses offer less protection against the Omicron variant

The drug received conditional marketing authorisation in the UK from the MHRA in November

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung […]

Fierce JPM Week: Novo Nordisk plans more patient outreach, doctor education as Wegovy launch works through supply woes […]